Similar Blog Posts

MOLCURE and Teijin Pharma Sign New Agreement to Continue Joint Research Using MOLCURE’s AI Platform, January 7

MOLCURE and Teijin Pharma Sign New Agreement to Continue Joint Research Using MOLCURE’s AI Platform, January 7

Read more
帝人ファーマとのAI技術を活用した共同研究に関する新規継続契約締結のお知らせ, January 7

帝人ファーマとのAI技術を活用した共同研究に関する新規継続契約締結のお知らせ, January 7

Read more
CEO/CSO Tamaki to Speak at the 469th CBI Society Seminar, December 9

CEO/CSO Tamaki to Speak at the 469th CBI Society Seminar, December 9

Read more
CEO/CSO玉木が第469回CBI学会講演会に登壇, December 9

CEO/CSO玉木が第469回CBI学会講演会に登壇, December 9

Read more